DIALYSIS · CCN 492591

DaVita Fairfax Dialysis Center

FAIRFAX, VA 22031

DialysisProfitDaVita
$4.4M
TOTAL REVENUE
21.0%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.4M
Total costs
$3.4M
Operating income (rev − costs)
$918K
Operating margin
21.0%
Total charges
$4.3M
Total treatments
9,971
Dialysis stations
24

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.6428—
Fistula Rate
DFC_FISTULA_RATE
75.576—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.1131—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
2——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
101.248—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1376—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
21.8215—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
17.762—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
21.729—
Standardized ED Visits Ratio
DFC_SEDR
1.5330—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
13.527—